ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

38,306Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 5176

$3.16M Total Retail Price of All Prescriptions

Rank: 13 out of 5176

1,205 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

1% of this provider’s 1,205 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

5% of this provider’s 1,205 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

3% of this provider’s 36,296 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

50% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$83 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
AMLODIPINE BESYLATE 2,212 2,078 1 2
ALENDRONATE SODIUM 2,062 1,952 10 2 18
NEXIUM 2,048 1,952 10 3 16
SIMVASTATIN 1,885 1,722 4 1
LIDODERM 1,247 1,213 5 59
CELEBREX 1,025 979 6 80
LOVAZA 907 874 7 43
ATORVASTATIN CALCIUM 903 862 8 9
CRESTOR 710 672 9 15
DIOVAN HCT 708 693 10 39
CREON 669 666 11 111
LOSARTAN POTASSIUM 652 589 12 14
METFORMIN HCL 613 588 13 7
DIOVAN 585 534 14 19
ZOLPIDEM TARTRATE 577 566 15 17
GLYBURIDE-METFORMIN HCL 564 507 R 16 76
OMEPRAZOLE 478 437 17 3
GLIMEPIRIDE 456 432 18 37
LIPITOR 444 438 19 51
EVISTA 439 413 20 65
ATENOLOL 435 417 21 12
PLAVIX 425 404 22 29
LOSARTAN-HYDROCHLOROTHIAZIDE 424 408 23 35
TAMSULOSIN HCL 412 393 24 20
GLIPIZIDE XL 407 365 25 83
METOPROLOL SUCCINATE 402 384 26 11
CIPROFLOXACIN HCL 394 352 27 84
METOPROLOL TARTRATE 388 379 28 6
LISINOPRIL 382 368 29 5
CLOPIDOGREL 380 366 30 26
ZOSTAVAX 351 321 31 219
MELOXICAM 348 328 32 53
DONEPEZIL HCL 320 320 33 28
LEVOTHYROXINE SODIUM 304 285 34 4
CARVEDILOL 303 278 35 24
ACTOS 286 265 36 85
IBANDRONATE SODIUM 285 280 37 211
AMOXICILLIN 276 256 38 163
HYDROCHLOROTHIAZIDE 272 272 39 10
RANITIDINE HCL 239 210 40 36
SINGULAIR 216 205 41 62
BONIVA 214 210 42 236
BENICAR 209 200 43 100
NIFEDIPINE ER 202 202 44 48
FLUOCINONIDE 197 176 45 165
AMLODIPINE BESYLATE-BENAZEPRIL 185 173 46 55
IBUPROFEN 182 173 47 72
FLUTICASONE PROPIONATE 181 172 48 38
ALLOPURINOL 181 159 48 41
DEXILANT 180 180 50 118
FELODIPINE ER 169 169 51 128
EXFORGE 167 167 52 126
JANUMET 164 156 53 77
MECLIZINE HCL 158 158 54 81
METOCLOPRAMIDE HCL 157 150 55 176
NAPROXEN 152 139 56 95
VOLTAREN 152 151 56 97
GABAPENTIN 150 142 58 21
MEGESTROL ACETATE 146 145 R 59 263
ATENOLOL-CHLORTHALIDONE 142 129 60 161
AMMONIUM LACTATE 138 133 61 91
ENALAPRIL MALEATE 135 122 62 22
JANUVIA 134 129 63 25
ACTONEL 132 132 64 134
SERTRALINE HCL 132 127 64 30
FUROSEMIDE 132 131 64 8
MONTELUKAST SODIUM 130 123 67 123
ADVAIR DISKUS 128 122 68 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 124 114 69 49
RAMIPRIL 119 100 70 50
BENICAR HCT 115 115 71 110
WARFARIN SODIUM 115 110 71 13
SYNTHROID 115 113 71 33
TRICOR 115 115 71 148
LYRICA 111 110 75 133
ISOSORBIDE MONONITRATE ER 109 105 76 44
FAMOTIDINE 108 107 77 58
ACTOPLUS MET 106 94 78 268
PIOGLITAZONE HCL 103 97 R 79 237
ACETAMINOPHEN-CODEINE 98 97 S3 80 127
DETROL LA 91 90 81 249
AVODART 87 87 82 107
PRAVASTATIN SODIUM 84 84 83 23
TRAMADOL HCL-ACETAMINOPHEN 83 78 84 116
MEGACE ES 83 83 R 84 423
SPIRIVA 80 74 86 54
LOPERAMIDE 78 72 87 329
VESICARE 72 72 88 210
FENOFIBRATE 72 57 88 102
FLECTOR 72 65 88 282
PROAIR HFA 71 71 91 60
ZENPEP 70 70 92 372
ESCITALOPRAM OXALATE 69 69 93 89
ZETIA 69 69 93 68
SUCRALFATE 67 64 95 303
CHLORHEXIDINE GLUCONATE 67 54 95 202
VALSARTAN-HYDROCHLOROTHIAZIDE 65 59 97 292
SOLARAZE 65 53 97 157
FEXOFENADINE HCL 64 53 99 358
METFORMIN HCL ER 63 57 100 57
AZOR 62 62 101 194
LOVASTATIN 62 60 101 46
AMOX TR-POTASSIUM CLAVULANATE 61 52 103 141
BYSTOLIC 60 60 104 96
TRILIPIX 60 60 104 187
CLOTRIMAZOLE-BETAMETHASONE 59 57 106 94
HYDROXYZINE HCL 59 56 R 106 213
RESTASIS 59 55 106 353
NAMENDA 59 59 106 47
PROCTOZONE-HC 58 52 110 171
FINASTERIDE 58 58 110 69
CYCLOBENZAPRINE HCL 58 51 R 110 143
LANSOPRAZOLE 58 57 110 113
ALCOHOL SWABS 56 52 114 115
METHYLPREDNISOLONE 56 47 114 218
CLOBETASOL PROPIONATE 55 52 116 130
EXFORGE HCT 55 55 116 266
LEVETIRACETAM 54 54 118 92
HYDROCODONE-ACETAMINOPHEN 52 50 S3 119 27
VYTORIN 52 41 119 152
TRAMADOL HCL 51 51 121 40
GLYBURIDE 51 51 R 121 67
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.